Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Stress Urinary Incontinence (SUI): later-stage trial registry
2 of 3 indexed Stress Urinary Incontinence (SUI) trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Stress Urinary Incontinence (SUI): 3 US clinical trials tracked, 2 recruiting.
Stress Urinary Incontinence (SUI) is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Procter and Gamble, running 1 of these trials.
Enrollment posture brief
Registry condition stress-urinary-incontinence-sui
OPEN 2 | RECR 67% | LATE 1 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Stress Urinary Incontinence (SUI) lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Stress Urinary Incontinence (SUI) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Stress Urinary Incontinence (SUI) is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Pivotal Study of Voro Urologic Scaffold
Levee Medical
NCT06873581
Evaluating SUI-100™, A Non-Invasive Device for the Treatment of Stress Urinary Incontinence
Acoustic Wave Cell Therapy
NCT06862648
A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence (SUI)
Procter and Gamble
NCT02131311
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Stress Urinary Incontinence (SUI) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Stress Urinary Incontinence (SUI) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Stress Urinary Incontinence (SUI) page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Stress Urinary Incontinence (SUI) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Procter and Gamble sponsors the most Stress Urinary Incontinence (SUI) trials on record, review their full trial history before evaluating a specific study. See Procter and Gamble's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Stress Urinary Incontinence (SUI) condition card totals 3 registered trials; most-linked intervention disposable, single-use pessary; top US site state Arizona. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.